ViewRay Announces VA Oklahoma City Healthcare System Chooses ViewRays MRIdian MRI-Guided Radiation Therapy System

VRAYDelisted Stock  USD 0.04  0  5.67%   
Slightly above 62% of ViewRay's investor base is looking to short. The analysis of current outlook of investing in ViewRay suggests that many traders are alarmed regarding ViewRay's prospects. ViewRay's investing sentiment can be driven by a variety of factors including economic data, ViewRay's earnings reports, geopolitical events, and overall market trends.
  
ViewRay Announces VA Oklahoma City Healthcare System Chooses ViewRays MRIdian MRI-Guided Radiation Therapy System

Read at investing.com
Investing News at Macroaxis
  

ViewRay Fundamental Analysis

We analyze ViewRay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViewRay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViewRay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

ViewRay is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

ViewRay Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ViewRay stock to make a market-neutral strategy. Peer analysis of ViewRay could also be used in its relative valuation, which is a method of valuing ViewRay by comparing valuation metrics with similar companies.

Peers

ViewRay Related Equities

CVRXCVRx   5.58   
0%
73.0%
DCTHDelcath Systems   5.56   
0%
73.0%
BBLGBone Biologics   5.56   
0%
73.0%
HSCSHeart Test   2.17   
0%
28.0%
ATECAlphatec Holdings   0.11   
0%
1.0%
AVNSAvanos Medical   0.06   
1.0%
0%
AXGNAxogen   1.49   
19.0%
0%
INGNInogen   1.63   
21.0%
0%
AORTArtivion   1.74   
22.0%
0%
SGHTSight Sciences   2.49   
32.0%
0%
OFIXOrthofix Medical   2.69   
35.0%
0%
ESTAEstablishment Labs   2.81   
36.0%
0%
ANIKAnika Therapeutics   3.30   
43.0%
0%
VVOSVivos Therapeutics   6.24   
82.0%
0%
NPCENeuropace   6.26   
82.0%
0%
TIVCTivic Health   7.60   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in ViewRay Stock

If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios